100% Coverage, 100% Human-Verified
Flagging what matters most so expert reviewers never miss what counts
Flagging what matters most so expert reviewers never miss what counts
In most CNS trials, only 10-20% of assessment data ever gets reviewed by experts. That means up to 90% of sessions, along with potential scoring errors, protocol deviations, or missed clinical signals go completely unchecked.
Our solution changes that. It flags issues across 100% of your study data using AI, then routes only the highest-risk sessions to your expert reviewers for confirmation.
You get full visibility, verified by humans, without adding workload.
Signant's advanced AI-targeting transforms clinical assessment quality assurance by delivering 100% data coverage with 100% human verification of flagged assessments. This AI-powered solution enhances industry-standard central review by flagging potential issues across all assessments, enabling expert reviewers to focus their attention precisely where it matters most – without requiring additional human resources.
With our solution, you're not just improving quality assurance – you're setting a new standard for unprecedented endpoint reliability that positions your CNS trials for success.
Clinical interactions captured during visits
Scores and rating interviews captured using RaterStation® or transmitted to Signant Health
Derive interview transcripts from A/V recordings
Transcription output to AI-targeting
Automated transcript analysis
Identify ratings with possible administration and scoring issues
Clinical experts assess flagged ratings of concern
Human review of flagged ratings
Central Reviewer provides final review outcome, remediation, and commentary (as applicable)
Final human-qualified reviewed output
Clinical interactions captured during visits
Scores and rating interviews captured using RaterStation® or transmitted to Signant Health
Derive interview transcripts from A/V recordings
Transcription output to AI-targeting
Automated transcript analysis
Identify ratings with possible administration and scoring issues
Clinical experts assess flagged ratings of concern
Human review of flagged ratings
Central Reviewer provides final review outcome, remediation, and commentary (as applicable)
Final human-qualified reviewed output
Your expert reviewers still review the same volume of data,
now with AI-powered targeting to focus on assessments that truly matter most.
.png?width=89&height=89&name=01%20(1).png)
.png?width=89&height=89&name=01%20(2).png)
.png?width=89&height=89&name=01%20(3).png)
.png?width=89&height=89&name=01%20(4).png)

Signant Health's 25+ years of evidence generation generation experience

600+ sponsors and CROs trust, including all Top 20 pharma

Global network of 800+ expert clinical reviewers

Proven track record in CNS endpoint quality
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics.
Learn more at www.signanthealth.com.